about
The ketogenic diet as a treatment paradigm for diverse neurological disordersNon-pharmacological interventions for people with epilepsy and intellectual disabilitiesA ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotypeThe low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studiesKetogenic diet for obesity: friend or foe?Harnessing the power of metabolism for seizure prevention: focus on dietary treatmentsSeizure-induced oxidative stress in temporal lobe epilepsyNutritional Aspects of Treatment in Epileptic PatientsKetones prevent oxidative impairment of hippocampal synaptic integrity through KATP channelsPharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy.Synergistic roles for G-protein γ3 and γ7 subtypes in seizure susceptibility as revealed in double knock-out mice.BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures.The ketogenic diet in a pill: is this possible?Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.Treatment of paroxysmal dyskinesias.Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.Potential therapeutic use of the ketogenic diet in autism spectrum disordersThe ketogenic diet and other dietary treatments for refractory epilepsy in childrenPotent anti-seizure effects of D-leucine.A gestational ketogenic diet alters maternal metabolic status as well as offspring physiological growth and brain structure in the neonatal mouse.Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs.Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?The ketogenic diet: proposed mechanisms of action.Gestational ketogenic diet programs brain structure and susceptibility to depression & anxiety in the adult mouse offspringA ketogenic diet reduces long-term potentiation in the dentate gyrus of freely behaving rats.Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus.Pharmacotherapy for Dravet Syndrome.Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats.The use of ketogenic diet in special situations: expanding use in intractable epilepsy and other neurologic disordersEfficacy of the ketogenic diet in the 6-Hz seizure test.Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in ratsExogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats.SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures.Bioenergetic medicine.Excitatory action of GABA on immature neurons is not due to absence of ketone bodies metabolites or other energy substrates.Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?Ketogenic diets: new advances for metabolism-based therapies.Nutrition and acne: therapeutic potential of ketogenic diets.Anticonvulsant Effects of β-Hydroxybutyrate in Mice.Diabetes and epilepsy in children and adolescents.
P2860
Q21129287-5666D1E8-F2F1-4400-86E5-3B7B5F93A7B6Q24187245-71B489DE-CB4D-40F5-831B-21E20EDDF7C0Q24650359-C90CF6B7-ED4E-47BD-81AC-9C808D19FFA7Q26823338-7AE71A0D-DC81-45F8-95CC-D19E4B2204B7Q26824104-8FDAABA1-0033-49B5-8151-3CF0F3E98D0DQ26991869-CC26FF86-63E2-4782-8821-E3D2F2C6CE07Q27692712-9AD20FE1-D67F-4275-8616-6567C39F31EFQ28079443-545A1738-346E-4C5D-B2BB-814E9FB282C7Q28545771-B368BE13-68EA-4257-9AD2-9398052A31B9Q30496223-BCED4859-55C1-484B-B6A5-DC9EB6B1D55FQ30506222-895AEC4C-5CDE-43C2-A60C-13E3C6FE063DQ30514237-DC7F1634-C548-472C-9672-74A649D11D70Q33346385-95546677-792E-46DD-BDB7-1BF50FE8911CQ33569276-74C67E17-10B6-4499-AB73-5A4FBF47C32CQ34151861-654D4C28-A382-4D7F-A3B8-8B86DFAD5208Q34353543-227D18EE-821F-43BE-A5F3-7B82C1AD79BAQ34431317-225A1B3D-8F8C-45C0-9768-4D48BB4A4AC1Q34438651-7710DAE7-90C5-4D5D-A6A5-02188B19C643Q34479759-3681604A-D0BC-4D31-8626-1FB19D222F18Q34507934-EAAA00E3-4A57-46BB-819D-8CE8EE2C8C8BQ34559190-E85CAAB8-A5C8-4F6F-8471-A224B7F8A89AQ34777954-6A615FE3-52AF-4A33-87C5-81D85EDD0399Q34971363-66782769-3461-4B4B-B76D-AF4CF83B6DB2Q35024596-BF13F9C9-E8C2-4F61-8AFB-49530B0DDFEEQ35160483-338E8F77-A5AB-4F21-8894-39A667FAA512Q35901040-409506D2-CB01-4741-8437-146E36D5826CQ35953476-88DC5F10-1F1C-475F-AC63-993D55A43438Q35985369-1317ACD3-C1AF-487A-83A6-7BF1B4A8BDE1Q36266900-2A4CE93F-3030-4017-8757-046098679FF4Q36666089-FCCC2CCC-6B7F-440B-9B46-C58FB426168FQ36816412-23FD56B4-4781-4D28-BF5F-4A799520B594Q37475036-5F6A42D6-84B8-4D88-AE7D-C250BBAFEACBQ37576524-6CD48AAB-8DC6-4E73-8946-DFF378EFC23FQ37686246-756CE688-43A3-42BF-BCAF-D3F6B8B72189Q37892605-F3E2B444-C73C-4EF6-8583-1B34036A1DB6Q37920144-71B6819D-8DCE-4E91-8A40-04492BFBADE0Q37982950-589D5869-2E53-4939-A093-62900096285BQ37983368-9862C16F-E617-451C-9A12-CA1B3CE09E10Q38263584-2C8AE3C4-C890-466C-9A38-12939DEFA4B0Q38366484-457EF5EC-011A-4E2A-9DF6-9E267B7CCAC8
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The neuropharmacology of the ketogenic diet
@ast
The neuropharmacology of the ketogenic diet
@en
The neuropharmacology of the ketogenic diet
@nl
type
label
The neuropharmacology of the ketogenic diet
@ast
The neuropharmacology of the ketogenic diet
@en
The neuropharmacology of the ketogenic diet
@nl
prefLabel
The neuropharmacology of the ketogenic diet
@ast
The neuropharmacology of the ketogenic diet
@en
The neuropharmacology of the ketogenic diet
@nl
P2860
P1433
P1476
The neuropharmacology of the ketogenic diet
@en
P2093
Eileen P G Vining
Maciej Gasior
P2860
P304
P356
10.1016/J.PEDIATRNEUROL.2007.02.008
P407
P577
2007-05-01T00:00:00Z